drugset / Trial / NCT03201952

Examination of the Metabolic Effects of Direct Bile Salt Delivery to the Ileum in Humans

NCT03201952

Phase 1 Terminated 2 enrolled Vanderbilt University Medical Center
RandomizedCrossoverSingle-blindBasic science

Summary

This project will evaluate distal intestinal bile salt administration in humans by deliving ursodeoxycholic acid (UDCA) into the terminal ileum of subjects with a pre-existing ileostomy and assessing several hormone levels following an oral glucose tolerance test compared to a placebo.

Timeline

Start
2018-02-01
Primary completion
2020-05-01
Completion
2020-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ursodeoxycholic Acid Small molecule 300 mg Other

Indications